MedTrace Logo

Parkinson's Disease and Digestive Health

NCT04032262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-07-20

No results posted yet for this study

Summary

This study focuses on the relationship between the brain and the gut, and additionally will foster collaboration between Movement Disorder experts and Neurogastroenterologists to provide critical information and lead to innovative therapies in the future to treat GI dysfunction of Parkinson's Disease.

Conditions

Interventions

DIAGNOSTIC_TEST

Gastrointestinal and Parkinson's Disease

Subjects with Parkinson's disease will come for visits that will contain questionnaires about their PD, their bowel movements, and do further tests using anal rectal probes to understand further their constipation, and other tests to gather data on their digestion.

Sponsors & Collaborators

  • Parkinson's Disease Foundation

    collaborator OTHER

  • Augusta University

    lead OTHER

Principal Investigators

  • Amol Sharma, MD · Augusta University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-04
Primary Completion
2020-07-30
Completion
2021-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04032262 on ClinicalTrials.gov